CR9288A - Celulas estromales de medula osea para la inmunoproteccion de celulas madre neurales transplantadas - Google Patents

Celulas estromales de medula osea para la inmunoproteccion de celulas madre neurales transplantadas

Info

Publication number
CR9288A
CR9288A CR9288A CR9288A CR9288A CR 9288 A CR9288 A CR 9288A CR 9288 A CR9288 A CR 9288A CR 9288 A CR9288 A CR 9288A CR 9288 A CR9288 A CR 9288A
Authority
CR
Costa Rica
Prior art keywords
cells
immunoprotection
transplanted neural
medula
osea
Prior art date
Application number
CR9288A
Other languages
English (en)
Inventor
R Mcintosh Kevin
Original Assignee
Negocios Farini Sa
Custom Med Applications Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Negocios Farini Sa, Custom Med Applications Inc filed Critical Negocios Farini Sa
Publication of CR9288A publication Critical patent/CR9288A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invencion comprende metodos y composiciones para reducir una respuesta inmune a un recipiente del trasplante que recibe las NSC mediante el tratamiento de dicho recipiente con una cantidad de medula osea estromal efectiva para reducir o inhibir el rechazo por el hospedero de las NSC.
CR9288A 2005-01-11 2007-08-06 Celulas estromales de medula osea para la inmunoproteccion de celulas madre neurales transplantadas CR9288A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64343605P 2005-01-11 2005-01-11

Publications (1)

Publication Number Publication Date
CR9288A true CR9288A (es) 2008-01-15

Family

ID=36677954

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9288A CR9288A (es) 2005-01-11 2007-08-06 Celulas estromales de medula osea para la inmunoproteccion de celulas madre neurales transplantadas

Country Status (13)

Country Link
US (1) US20060153819A1 (es)
EP (1) EP1841322A4 (es)
JP (1) JP2008526891A (es)
KR (1) KR20070100351A (es)
CN (1) CN101137292A (es)
AU (1) AU2006205033A1 (es)
BR (1) BRPI0606678A2 (es)
CA (1) CA2593668A1 (es)
CR (1) CR9288A (es)
IL (1) IL184470A0 (es)
MX (1) MX2007008437A (es)
RU (1) RU2007130695A (es)
WO (1) WO2006076374A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010117464A1 (en) * 2009-04-09 2010-10-14 Sangamo Biosciences, Inc. Targeted integration into stem cells

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733542A (en) * 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
WO1999046366A1 (en) * 1998-03-13 1999-09-16 Osiris Therapeutics, Inc. Uses for humane non-autologous mesenchymal stem cells
DE69929681T2 (de) * 1998-03-18 2006-10-26 Osiris Therapeutics, Inc. Mesenchymale stammzellen für die prävention und behandlung von immunantworten bei transplantationen
US6368636B1 (en) * 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
AU6276899A (en) * 1998-09-29 2000-04-17 Diacrin, Inc. Transplantation of neural cells for the treatment of ischemic damage due to stroke
US20050169896A1 (en) * 1999-05-14 2005-08-04 Henry Ford Health System Bone marrow transplantation for treatment of stroke
WO2001076507A2 (en) * 2000-04-11 2001-10-18 The University Of Miami Use of oxygen carriers to improve grafted cell survival in neural transplantation
GB2386125B (en) * 2000-11-22 2005-02-23 Geron Corp Tolerizing allografts of pluripotent stem cells

Also Published As

Publication number Publication date
RU2007130695A (ru) 2009-02-20
EP1841322A1 (en) 2007-10-10
WO2006076374A1 (en) 2006-07-20
AU2006205033A1 (en) 2006-07-20
CA2593668A1 (en) 2006-07-20
IL184470A0 (en) 2007-10-31
BRPI0606678A2 (pt) 2009-07-07
CN101137292A (zh) 2008-03-05
MX2007008437A (es) 2008-02-19
EP1841322A4 (en) 2009-12-09
JP2008526891A (ja) 2008-07-24
US20060153819A1 (en) 2006-07-13
KR20070100351A (ko) 2007-10-10

Similar Documents

Publication Publication Date Title
DOP2016000107A (es) PIRROLO[1,2-f][1,2,4]TRIAZINAS ÚTILES PARA TRATAR INFECCIONES POR EL VIRUS SINCITIAL RESPIRATORIO.
AR054465A1 (es) Concentrado para suspender en aceites
CL2017001686A1 (es) 5-fluoro-4-imino-3-(alquil/alquil sustituido)-1-(arilsulfonil)-3,4-dihidropirimidin-2(1h)-ona como tratamiento de semillas.
CR20130175A (es) Métodos y composiciones que contienen jasmonato o compuestos relacionados para promover la actividad de biodefensa en las plantas
CL2017000893A1 (es) Composición que comprende un agente de control biológico de la especie bacillus subtilis y un fungicida seleccionado de protioconazol, espiroxamina, y tebuconazol; uso de la composición, procedimiento que la utiliza; y un kit que la contiene.
AR089596A1 (es) Cepas de bradyrhizobium
GT201000029A (es) Composiciones y metodos para controlar nematodos
ECSP11011310A (es) Análogos carba - nucleósido para tratamiento antiviral
CR10136A (es) Nucleósidos antivirales
CL2011002116A1 (es) Compuestos derivados de acetamida sustituida por n-heteroaril o 2-heteroaril como moduladores de las señales wnt; composiciones farmaceuticas que los comprenden; y su uso en el tratamiento del cancer, rechazo de injerto de riñon, osteoartritis, parkinson, entre otras.
CL2009001476A1 (es) Compuestos derivados de 2,4-diamin-n2-fenil pirimidina sustituidos, mediadores de la inhibicion de igf-1r; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de enfermedades autoinmune, por trasplante, infecciosas o un trastorno proliferativo celular.
BR112017011422A2 (pt) compostos de ácido isoazol hidro¬xâmico como inibidores de lpxc
AR062227A1 (es) Metodo para mejorar el crecimiento de las plantas reduciendo las infecciones viricas
CR11453A (es) Compuestos nucleosidos antivirales
ECSP20084373A (es) Tiofencarboxamidas sustituidas y análogos de las mismas
CO6511234A2 (es) Métodos de multiplicación vegetativa de plantas herbáceas
EA201890314A3 (ru) Композиции, содержащие липохитоолигосахарид и микроорганизм для усиления роста растения
CL2017001903A1 (es) Composición novedosa para uso en el incremento de eficacia de injerto de células madre hematopoyéticas después del trasplante
AR086326A1 (es) Metodo para promover el crecimiento de plantas
UY30896A1 (es) Composicion fitosanitaria
CL2017002320A1 (es) Archaebacteria en alimento para animales bioactivo, método para hacer la composición y métodos que emplean la composición
AR046729A1 (es) Concentrado de tienil-sulfonamidas para suspender en aceites
CR9288A (es) Celulas estromales de medula osea para la inmunoproteccion de celulas madre neurales transplantadas
PE20151248A1 (es) Derivados de ciclopentano como inhibidores de catepsinas
CR20110589A (es) Compuestos y métodos para controlar hongos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)